Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the ... ( NEW YORK May 28 /- The UltraPulse CO2...)

Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the Today Show

Date:5/28/2009

NEW YORK, May 28 /PRNewswire/ -- The UltraPulse CO2 fractional laser was featured today on NBC's Today Show as an exciting and revolutionary new treatment for scars. During the broadcast, triplets who were severely burned in a fire as infants told their personal story and discussed recent treatments with the Lumenis UltraPulse laser. After only two treatments with the groundbreaking ActiveFX and DeepFX technologies, the triplets Jordan, Trae and Chandra Berns have achieved noticeable improvement in the appearance of their scars. The triplets' incredible story was also featured in the May issue of Glamour.

Dr. Kenneth Beer and Dr. Jill Waibel, the West Palm Beach physicians treating the triplets, are pioneers in the application of fractional lasers for the treatment of scars. They chose the Lumenis' UltraPulse system due to its dual-treatment modality.

"My objective when treating scars is two-fold: first, I ablate away portions of the scar by drilling micro-channels deep into the affected area, thereby eliminating part of the scar and enabling increased mobility and improved appearance. This treatment is known as DeepFX, and it serves to create new healthy tissue replacing the bulky scar tissue. Then, I use the ActiveFX treatment on the surface of the skin to smooth and even out the texture as well as remove any discoloration and unwanted pigmentation," explained Dr. Waibel. "This dual-treatment regimen is known as TotalFX, and it offers a unique inside out approach that can be applied to treating all scars including burn scars, acne scars, and traumatic injury scars."

"Dr. Beer and Dr. Waibel contacted Lumenis after the Berns sisters came to their Palm Beach office for a consultation. The doctors felt that the UltraPulse laser would be the ideal treatment choice for the triplets. Lumenis was very happy to support the extensive treatments that the Berns sisters required. We will continue to s
'/>"/>

SOURCE Lumenis
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4
Related medicine news :

1. Nosespray vaccine using aloe vera has exciting potential, researcher says
2. Exciting New Plan from John Edwards on AIDS; Plan is Bold and Achievable, say New Hampshire Activists
3. 3 Tesla + 70 cm + Tim = The Most Exciting Equation in MRI
4. Leicester scientist announces unexpected and exciting advance in study of cancer type
5. WRAIR investigators pioneering work on an exciting new class of antimalarial compounds
6. Cholera study provides exciting new way of looking at infectious disease
7. Reflex Stock Launches Exciting New Editorial Image Collections to the Worldwide Publishing Industry
8. New NAMC Member Service! Complimentary Webinars for NAMC Members - On Topics You Need to Know! Sign Up Today for This New and Exciting Educational Program!
9. Exciting discovery could stop cancer from killing people
10. HotHead Technologies Heat Sensor Shows Exciting Potential by Kennesaw State University Researchers
11. Scientists eavesdrop on the exciting conversations within cells

Post Your Comments:

(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int

(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for

(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W

(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s

(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification [0] Distributor Announces New Applications for Wind Turbines [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children [0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment

...he misuse of ambulances of government hospitals by...g that their services be availed of only by patie...r and Justice S.N. Agrawal said: "No ambulance of ...on a petition, the bench said all vehicles fitted ...

...rnor, James E. McGreevy appears to be knocking on ...n the news for the right reasons. He has been wel...lian. Former Gov. James E. McGreevy, who wa...ly undergoing the church's "discernment" phase, wh...

... when her pictures appeared in magazine articles a... all that blew up, I felt terrible. It appeared th... not. I am thin because that's what I am, and I wa...nightley had just finished filming "Pirates of the...

...tes (UAE) said the government is working to draft ...he country's prevention programme of genetic diso...on the mother or child's health. But the choice to...e ministry of health was quoted as saying in Gulf ...

...onfirmed that the malfunction of a gene causes sch...ublished Thursday's issue of the journal Neuron. ...offer a possible animal model for developing treat...e researchers sought to explore the consequences o...

...aine headaches are more than twice as likely to al...ion or anxiety than soldiers who do not have migr...olved 3,621 United States Army soldiers who were g...cent, completed the questionnaire. Of those, 19 pe...

Other Medicine News:Health News:Malfunction of Gene Causes Schizophrenia, Depression 2 Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2

High Court Warns Medical Staff Against Misuse of Ambulance Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary 'Skinny' Debate Upsets Actress Knightley Legalization of Therapeutic Abortion in UAE on the Cards Malfunction of Gene Causes Schizophrenia, Depression Migraines may Be a Symptom of Other Problems for Iraq Soldiers

(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab

(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre

(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,

Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9 Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2 Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2 Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3 Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 1 Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 2 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 1 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 2 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 3 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 4 Michael E DeBakey Journalism Award Recipients Announced 49243 1

[0] US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder [0] Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker [0] Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects

..., March 10 BioSpecifics Technologies Corp. (Nasda...g first in class collagenase-based products, today...n, will present a corporate overview at the upcomi...rence on Tuesday, March 17, 2009, at 9:30am ET at ...live webcast of the presentation can be accessed a...

...raClip(R) System Continues to Expand in the Europe..., Inc., the leader in the development of devices f...unced today that the first series of patients have...ystem at the Cardiocentro Ticino in Lugano, Switze... device commercially available in the European Uni...

Other Medicine Technology:First Swiss Patients Treated with the Percutaneous MitraClip(R) System 2 First Swiss Patients Treated with the Percutaneous MitraClip(R) System 3

BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference First Swiss Patients Treated with the Percutaneous MitraClip(R) System

Shandon Histobath 2

Liquichek Blood Gas Plus CO-Oximeter Control (IL)

Liquichek CK/LD Isoenzyme Control

Lyphochek Diabetes Control

Medicine Products:

Shandon Histobath 2 Liquichek Blood Gas Plus CO-Oximeter Control (IL)Liquichek CK/LD Isoenzyme Control Lyphochek Diabetes Control

Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the ...( NEW YORK May 28 /- The UltraPulse CO2...),Health